Perimembranous Ventricular Septal Defect
3
1
2
0
Key Insights
Highlights
Treatment Research
3 treatments under study, led by Transcatheter Device Closure Of Perimembranous Ventricular Septal Defects Pmvsds
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 3 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (3)
An International Multicenter Study on Transcatheter Device Closure of Perimembranous Ventricular Septal Defects
A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® PmVSD Occluder in Patients With Perimembranous Ventricular Septal Defects
Minimally Invasive Transthoracic Device Closure in Perimembranous Ventricular Septal Defect
Research Network
Common Treatments
- Transcatheter Device Closure Of Perimembranous Ventricular Septal Defects Pmvsds1
- Transthoracic Device Closure1
- Surgical Repair1
Active Sponsors
- Chinese Academy of Medical Sciences, Fuwai Hospital1
- Fondation Hôpital Saint-Joseph1
- Occlutech International AB1
Top Investigators
Marie Lannelongue Hospital, INSERM, UMR-S1358, UP-Saclay
Chinese Academy of Medical Sciences, Fuwai Hospital